Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > All

Total search results: 9789 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 84 85 86 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bayer AG. (2/22/11). "Press Release: Brazil’s CTNBio Approves Cotton with TwinLink Technology from Bayer CropScience". Monheim. 2011-02-22
Bayer AG. (2/22/11). "Press Release: Erica L. Mann Appointed New Head of Bayer HealthCare’s Consumer Care Division". Leverkusen. 2011-02-22
Biofrontera AG. (2/22/11). "Press Release: 880,000 Shares Subscribed in Capital Increase". Leverkusen. 2011-02-22
Scienion AG. (2/21/11). "Press Release: Euroimmun to Use Scienion Arrayer for Biochip Development and Production. Euroimmun AG Has Purchased Scienion’s sciFLEXARRAYER Technology". Dortmund & Berlin. 2011-02-21
High-Tech Gründerfonds Management GmbH. (2/21/11). "Press Release: Pepperprint Wins 30th German Industry’s Innovation Award". Bonn, Heidelberg & Frankfurt a. M.. 2011-02-21
Proteros Biostructures GmbH. (2/21/11). "Press Release: Dr. Axel Ullrich, Director at the Max Planck Institute of Biochemistry, Martinsried, Chooses Proteros as Preferred Service Partner for Kinase Drug Discovery". Martinsried. 2011-02-21
Intercell AG. (2/21/11). "Press Release: Intercell Announces Start of Pivotal Phase II/III Study in India for Vaccine to Protect Children from Japanese Encephalitis". Vienna & Hyderabad. 2011-02-21
Medigene AG. (2/21/11). "Press Release: MediGene and Pierre Fabre Sign Agreement for the Commercialization of Veregen in Mexico, Central America, Venezuela and Colombia". Martinsried. 2011-02-21
Ribocon GmbH. (2/18/11). "Press Release: Ribocon Participates in Community Initiative on Standardization of Marker Gene Submissions which Is to Be Published in Nature Biotechnology". 2011-02-18
Clariant AG. (2/16/11). "Press Release: Clariant Plans Acquisition of Süd-Chemie AG. Accerlating Profitable Growth – Addition of Future Technologies with High Growth Potential – Enterprise Value of EUR 2.0 Billion (CHF 2.5 Billion)". Muttenz. 2011-02-16
Fluidigm Corporation. (2/16/11). "Press Release: IMGM Laboratories Utilizes Fluidigm Access Array System for Targeted Re-sequencing Applications. IMGM the First Genomic Services Provider in Germany to Offer this Technology". South San Francisco, CA & Mar 2011-02-16
CovalX AG. (2/16/11). "Press Release: The USPTO Grants CovalX a New Patent for the Analysis of Therapeutic Protein Aggregates in the USA". Zürich. 2011-02-16
Ipsogen S.A.. (2/16/11). "Press Release: Revenue for the Year 2010 – 8.37M€ (+24%), Acceleration of Sales During the Second Half of 2010 and a Steady Growth in Consolidated Revenue Over the Year". Marseille. 2011-02-16
Biocrates Life Sciences AG. (2/16/11). "Pressemitteilung: OMICS – auf dem spannenden Pfad der personalisierten Medizin". München. 2011-02-16
Jomaa Pharma GmbH. (2/15/11). "Press Release: Jomaa Pharma and Medicines for Malaria Venture to Co-develop Novel Malaria Treatment Based on Fosmidomycin". Hamburg & Westerham. 2011-02-15
Bruker Corporation. (2/15/11). "Press Release: Bruker Installs NMR Metabolic Profiling Systems at Norwegian University of Science and Technology (NTNU) Trondheim for Research on Cancer Diagnostics and Treatment". Trondheim. 2011-02-15
Bruker Corporation. (2/15/11). "Press Release: Bruker Introduces Novel Optical Metrology Solution for Characterizing Lead Angle of Rotary Dynamic Sealing Surfaces". Tuscon, AZ. 2011-02-15
Evotec AG. (2/15/11). "Press Release: Evotec to Strengthen Its Compound Collection through a Collaboration with ChemBridge". Hamburg. 2011-02-15
NYSE Euronext. (2/15/11). "Press Release: Deutsche Boerse AG and NYSE Euronext Agree to Combine to Create the Premier Global Exchange Group". Frankfurt & New York. 2011-02-15
Biocrea GmbH. (2/14/11). "Press Release: Biocrea Announces Novel Treatment Opportunities for CNS Diseases. Company Has Filed US Patent on Novel, Brain-penetrating PDE2 and PD10 Inhibitors". Radebeul. 2011-02-14
PerkinElmer, Inc.. (2/14/11). "Press Release: PerkinElmer Acquires Chemagen Biopolymer-Technologie AG". Waltham, MA. 2011-02-14
Scil Technology GmbH. (2/14/11). "Press Release: Scil Technology Appoints Christian Nafe to Chief Executive Officer". Martinsried. 2011-02-14
Bruker Corporation. (2/14/11). "Press Release: Bruker to Host Pittcon 2011 Booth Tour for Financial Community". Billerica, MA. 2011-02-14
Evotec AG. (2/9/11). "Press Release: Expanding Its Drug Discovery Platform with Cutting-edge Technologies. [Evotec AG Signs Definititive Agreement to Acquire All Shares in Kinaxo Biotechnologies GmbH]". Hamburg. 2011-02-09
Nanohale AG. (2/9/11). "Press Release: Nanohale AG to Host Visit by Prominent Russian Insulin Researchers". 2011-02-09
AKos GmbH. (2/8/11). "Press Release: AKos GmbH Announces the Adoption of ChemAxon Marvin Java Applet as Structure Editor in CWM Global Search, the Internet Search Engine for Chemists and Biologists". Steinen. 2011-02-08
Geneva Bioinformatics (GeneBio) S.A.. (2/8/11). "Press Release: AB Sciex and GeneBio Team Up to Improve Interactive Library Searching for Mass Spectrometry". Foster City, CA & Geneva. 2011-02-08
MorphoSys AG. (2/7/11). "Press Release: MorphoSys Strengthens Patent Position on Lead Program MOR103". 2011-02-07
Bruker Corporation. (2/7/11). "Press Release: Bruker Launches pTD, a Compact, Lab Chip-based, Fully Automated and Fast Toxin ID System for Homeland Security". Washington, DC. 2011-02-07
Noxxon Pharma AG. (2/3/11). "Press Release: Noxxon Expands Management Team". Berlin. 2011-02-03
Metabolomic Discoveries GmbH. (2/3/11). "Press Release: Metabolomic Discoveries Announces Start of 1000 Metabolomes Program. Program Setup to Identify Diversity of Metabolites in Organisms, Food and Beverages". 2011-02-03
Activaero GmbH. (2/2/11). "Press Release: Activaero Raises EUR 5.0 Million in a Second Closing Series". 2011-02-02
Proteros Biostructures GmbH. (2/2/11). "Press Release: Proteros and SuperGen Enter into an Integrated Lead Discovery Agreement". Martinsried. 2011-02-02
Scil Proteins GmbH. (2/2/11). "Press Release: Scil Proteins Raises Financing of €24 Million". Halle (Saale). 2011-02-02
Roche. (2/2/11). "Press Release: Solid Overall Results. Mid-single Digit Sales Growth in Local Currencies Excluding Tamiflu – Strong Profit Growth – Promising Late Stage Pharmaceutical Pipeline of Twelve New Molecular Entities". Basel. 2011-02-02
Spectro Analytical Instruments GmbH. (2/1/11). "Press Release: Ametek Spectro Partners with SII Nanotechnology to Market IPC-OES and ICP-MS Instruments in Japan". Kleve. 2011-02-01
AB Sciex. (2/1/11). "Press Release: AB Sciex Announces the Appointment of Rainer Blair as President". Framingham, MA. 2011-02-01
Biotecon Diagnostics GmbH. (2/11). "Press Release: Biotecon Diagnostics Receives New AOAC Certificate for Its foodproof Listeria monocytogenes Deteciong Kit, 5’Nuclease". Potsdam. 2011-02-01
Molzym GmbH & Co. KG. (2/11). "Press Release: Researchers Identifiy Non-culturable Microbes from Bloodstream Infections". 2011-02-01
Delenex Therapeutics AG. (2/1/11). "Press Release: Delenex Therapeutics Complements Its Management. Delenex Appoints Eric de La Fortelle as CEO and Jakob Schlapbach as CFO". Schlieren. 2011-02-01
Mologen AG. (2/1/11). "Press Release: Mologen AG Very Successfully Completes Capital Increase. Private Placement Oversubscribed". Berlin. 2011-02-01
Ipsogen S.A.. (2/1/11). "Press Release: Ipsogen and Bio-Reference Laboratories Settle Lawsuit". Marseille. 2011-02-01
Valeant Pharmaceuticals International, Inc.. (2/1/11). "Press Release: Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.". Mississauga, ON & Zug. 2011-02-01
Qiagen N.V.. (1/31/11). "Press Release: Qiagen Reports Full-year and Fourth-quarter 2010 Results". Venlo. 2011-01-31
Actelion Ltd.. (1/28/11). "Press Release: Actelion and GSK Discontinue Clinical Development of Almorexant". Allschwil & London. 2011-01-28
Bayer AG. (1/28/11). "Press Release: Bayer and Zydus Cadila Sign Joint Venture Agreement to Strengthen Pharmaceutical Business in India". Berlin. 2011-01-28
Merck KGaA. (1/28/11). "Press Release: Merck Appoints Frederic Wohlwend as CIO". Darmstadt. 2011-01-28
Roche. (1/28/11). "Press Release: Early Successful Readout of Tarceva Study in a Distinct Form of Lung Cancer". Basel. 2011-01-28
Biofrontera AG. (1/27/11). "Press Release: Positive Review of the European Medicines Agency in the Approval Process of BF-200 ALA". Leverkusen. 2011-01-27
Novartis AG. (1/27/11). "Press Release: Innovation Drives Novartis to Double-digit Growth for 2010. Novartis Achied Strong Financial Results in 2010". Basel. 2011-01-27
Qiagen N.V.. (1/27/11). "Press Release: Qiagen Establishes Subsidiary in India to Accelerate Expansion. Qiagen India Pvt. Ltd. Will Sell Qiagen Products Directly in India, One of the Fastest Growing Biotech and Life Sciences Markets in Asia". Germantown, 2011-01-27
Tecan Group Ltd.. (1/27/11). "Press Release: New Trough from Tecan to Reduce Reagent Costs". Männedorf. 2011-01-27
Swedish Orphan Biovitrum AB. (1/27/11). "Press Release: Swedish Orphan Biovitrum Agrees with Fresenius Biotech to Distribute Removab". Stockholm. 2011-01-27
Merck KGaA. (1/25/11). "Press Release: Merck KGaA Intends to Name Matthias Zachert to Executive Board". Darmstadt. 2011-01-25
Tecan Group Ltd.. (1/25/11). "Press Release: Tecan Appoints Global Head of Human Resources. Markus Schmid Appointed Head of Corporate Human Resources & Internal Communications and Member of the Management Board". Männedorf. 2011-01-25
Tecan Group Ltd.. (1/25/11). "Press Release: Tecan Launches Innovative HydroSpeed Plate Washer". Männedorf. 2011-01-25
Pharmicell Europe GmbH. (1/25/11). "Press Release: RNL Bio Takes Over the Majority Holding’s of Pharmicell Europe". 2011-01-25
Cellzome. (1/24/11). "Press Release: Landmark Study Demonstrates that »Complexes Matter« in How Epigenetic Inhibitors Interact with Their Drug Targets. Cellzome Scientists Publish First Chemoproteomic Characterization of HDAC Inhibitors in Nature Biotech 2011-01-24
MorphoSys AG. (1/24/11). "Press Release: MorphoSys Announces Clinical Milestone within Boehringer Ingelheim Alliance. CTA Filing in Late December 2010 Represented th Eighth Clinical Milestone Last Year". 2011-01-24
Novartis AG. (1/24/11). "Press Release: Novartis Gains Approval for Gilenya as First-line Disease Modifying Oral Therapy for Multiple Sclerosis in Switzerland and Australia". Basel. 2011-01-24
Novartis AG. (1/24/11). "Press Release: Novartis Announces Agreement to Acquire Genoptix, Inc. in All Cash Offer. Novartis to Acquire Genoptix through an All Cash tender Offer at USD 25.00 per Share". Basel. 2011-01-24
SuppreMol GmbH. (1/24/11). "Press Release: SuppreMol Completes Successful Pre-IND Meeting with FDA". Martinsried. 2011-01-24
Apogenix GmbH. (1/24/11). "Press Release: Apogenix Provides Update in the Ongoing Phase II Clinical Trial of APG101 to Treat Glioblastoma. Data Safety Monitoring Board Recommends Continuation of Patient Recruitment". Heidelberg. 2011-01-24
4SC AG. (1/21/11). "Press Release: 4SC Presents Update on Phase II SHELTER Trial with Oral Pan-HDAC Resminostat at the 2011 Gastrointestinal Cancer Symposium". Planegg-Martinsried. 2011-01-21
Merck KGaA. (1/21/11). "Press Release: Merck KGaA Announces Outcome of Its Request Reexamination of CHMP Opinion for Cladribine Tablets in MS. CHMP Confirms Its Initial Negative Opinion Regarding the Marketing Authorization Application for Cladribine Tab 2011-01-21
Mologen AG. (1/21/11). "Press Release: Mologen AG. Good Tolerance of the Colorectal Cancer Medication MGN1703 in Phase II/III Study – Data Will Be Presented at the Symposium of ASCO in San Francisco". Berlin. 2011-01-21
MorphoSys AG. (1/21/11). "Press Release: MorphoSys Reports Preliminary, Unaudited Financial Results for 2010 and Provides First Outlook on 2011". 2011-01-21
Novartis AG. (1/21/11). "Press Release: Novartis Gains Positive CHMP Opinion for Gilenya, First Oral Multiple Sclerosis Treatment Recommended for Approval in the European Union". Basel. 2011-01-21
4SC AG. (1/20/11). "Press Release: 4SC Announces First Patient Dosed in Phase I/II SHORE Study in KRAS-mutant Colorectal Cancer Patients with Resminostat". Planegg-Martinsried. 2011-01-20
Evotec AG. (1/20/11). "Press Release: Collaboration with Takeda Cambridge for Multi-target Hit Identification". Hamburg. 2011-01-20
Kompetenznetz Asthma und COPD. (1/20/11). "Pressemitteilung: Software für die pneumologische Zukunft". 2011-01-20
Lead Discovery Center GmbH. (1/20/11). "Press Release: Lead Discovery Center and Merck KGaA Enter Collaboration for the Discovery of Anti-cancer Compounds. Research Collaboration May Realize the Potential of Kinase Inhibitors as a Means for Cancer Treatm 2011-01-20
Universität Innsbruck. (1/20/11). "Pressemitteilung: KIX – das fliegende Eiweiß. Forscher um Kathrin Breuker haben ein Protein entdeckt, das auch im gasförmigen Zustand über lange Zeit stabil gefaltet bleibt". 2011-01-20
Messe München GmbH. (1/20/11). "Press Release: Industry Portal Expanded – Relaunch of". Munich. 2011-01-20
AiCuris GmbH & Co. KG. (1/19/11). "Press Release: Dr. Marie-Paule Richard to Join AiCuris as CMO". Wuppertal. 2011-01-19
BioRegio STERN Management GmbH. (1/19/11). "Pressemitteilung: Kurze Wege für neue Krebsmedikamente". 2011-01-19
Merck KGaA. (1/19/11). "Press Release: Merck KGaA. Erbitux Long-term Survival Benefit for mCRC Patients Confirmed with FOLFOX". San Francisco, CA & Darmstadt. 2011-01-19
Roche. (1/19/11). "Press Release: Roche Personalized Investigational Medicine Shows Survival Benefit in Advanced Skin Cancer. Phase III Study Shows Promising Results for RG7204 in BRAF V600 Mutation-positive Metastatic Melanoma". Basel. 2011-01-19
Centogene Holding AG. (1/18/11). "Press Release: Michael Schlenk New Chief Executive Officer of Centogene Holding AG". Freiburg. 2011-01-18
Boehringer Ingelheim. (1/18/11). "Press Release: Boehringer Ingelheim to Purchase Amgen’s Fremont (USA) Facility. Boehringer Ingelheim to Strengthen Global Biopharma Presence, Amgen to Maintain Strong Presence". Thousand Oaks, CA & Ingelheim. 2011-01-18
Universität Kassel. (1/18/11). "Press Release: The German-Russian Cooperation Network Biotechnology 2011–2013 Funded by the German Federal Ministry of Education and Research (BMBF)". 2011-01-18
Ipsogen S.A.. (1/17/11). "Press Release: Ipsogen Acquires a License from Stanford University of LNK Mutations". Marseille. 2011-01-17
Boehringer Ingelheim. (1/17/11). "Press Release: for People on the Move. New Free Information Channel". Ingelheim. 2011-01-17
Roche. (1/17/11). "Press Release: 454 Life Sciences, University of Florida, and DOE JGI Sequence Sweet Orange Genome, Publish Annotated Assembly to Public Database". Branford, CT. 2011-01-17
Roche. (1/17/11). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. 2011-01-17
InProcess Instruments Gesellschaft für Prozessanalytik mbH. (1/17/11). "Press Release: InProcess Instruments Invests in Bremen and Creates New Jobs". 2011-01-17
Agennix AG. (1/17/11). "Press Release: Agennix AG Announces Longer-term Mortality Data from Talactoferrin Phase II Trial in Severe Sepsis Presented at 40th Critical Care Congress". Planegg. 2011-01-17
Domain Therapeutics S.A.. (1/17/11). "Press Release: Domain Therapeutics and Merck Serono Announce an Agreement to Develop Drugs for Parkinson’s Disease. Merck Serono to Develop Domain Therapeutics’ mGluR4 Allosteric Modulators". Strasbourg. 2011-01-17
Mologen AG. (1/14/11). "Press Release: Mologen AG Is Starting an Important Business Year with a Capital Increase". Berlin. 2011-01-14
Epigenomics AG. (1/14/11). "Pressemitteilung: Veröffentlichung nach § 26 Abs. 1 WpHG über die Veränderung von Stimmrechtsanteilen nach § 21 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung". Berlin. 2011-01-14
Epigenomics AG. (1/13/10). "Press Release: Epigenomics Provides Update on Progress with US Product Development for Epi proColon". Berlin & Seattle, WA. 2011-01-13
Evotec AG. (1/13/10). "Press Release: Milestone Payment Received from Boehringer Ingelheim". Hamburg. 2011-01-13
High-Tech Gründerfonds Management GmbH. (1/13/11). "Press Release: Capital for Caterna GmbH". Bonn & Dresden. 2011-01-13
Medigene AG. (1/13/11). "Press Release: MediGene Concludes an Agreement with Laboratoires Expanscience for the Commercialization of Veregen in France". Martinsried. 2011-01-13
Mologen AG. (1/13/11). "Press Release: Mologen AG Announces Its Decision on a Capital Increase from Authorized Capital". Berlin. 2011-01-13
Biocrates Life Sciences AG. (1/13/11). "Press Release: Metabolomic Biomarker Research for the Early Detection of Diabetes. International Expert Meeting on the Current Status, Benefits, and Opportunities of Metabolomics in the Nutritional Sciences, Diabet 2011-01-13
Geneva Bioinformatics (GeneBio) S.A.. (1/13/11). "Press Release: neXtProt. Product Release Announcement". Geneva & Lausanne. 2011-01-13
Evolva Holding S.A.. (1/13/11). "Press Release: Evolva Enters into Collaboration with International Flavors & Fragrances Inc. Evolva’s Third Contract in Food & Nutrition". Reinach. 2011-01-13
Cenix BioScience GmbH. (1/12/11). "Press Release: Cenix BioSciences Grows, Establishing New R&D Subsidiary in Flanders, Belgium". Dresden. 2011-01-12
MorphoSys AG. (1/12/11). "Press Release: MorphoSys Announces Clinical Milestone from Strategic Alliance". 2011-01-12
next pagenext page 1 2 3 ... 84 85 86 ... 96 97 98  next pagenext page


Picture [LSE] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top